CMS Issues Moratorium on DMEPOS Supplier Enrollment to Combat Fraud
CMS pauses new supplier enrollment in Medicare DMEPOS for 6 months to enhance fraud detection. Significant implications for healthcare integrity and compliance.
CMS pauses new supplier enrollment in Medicare DMEPOS for 6 months to enhance fraud detection. Significant implications for healthcare integrity and compliance.
Two insurance executives sentenced for ACA fraud, highlighting the need for compliance and integrity in healthcare. Key takeaways for the industry.
Explore upcoming changes in healthcare enforcement and compliance strategies ahead of 2026. Stay informed to navigate regulatory risks in healthcare effectively.
Discover the effects of Medicare's three-day hospitalization rule on patient care and skilled nursing facility utilization. Explore key findings and implications for providers.
Explore Medicare's new pilot program and its implications for the insurance industry, focusing on prior authorization and AI integration to improve efficiency.
Discover the latest updates on Medicare Advantage audit procedures, CMS's strategies, and implications for insurers following recent court decisions.
Explore the scrutiny of UnitedHealth Group's Medicare Advantage strategies and their impacts on payments, risk adjustment, and regulatory compliance in the insurance industry.
Explore California's APL 26-002 on COVID-19 testing requirements for health insurers, ensuring compliance and financial responsibilities under SB 510.
Kaiser Permanente's $556 million Medicare fraud settlement highlights crucial compliance challenges in the insurance industry. Learn more about the implications for insurers.
Discover the latest changes to the DMEPOS Competitive Bidding Program by CMS and what it means for healthcare suppliers and regulatory compliance.